nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—hypertension—metabolic syndrome X	0.94	1	CtDrD
Doxazosin—Gastrointestinal tract irritation—Metformin—metabolic syndrome X	0.00314	0.086	CcSEcCtD
Doxazosin—Nail disorder—Metformin—metabolic syndrome X	0.00173	0.0474	CcSEcCtD
Doxazosin—Fungal infection—Metformin—metabolic syndrome X	0.00145	0.0398	CcSEcCtD
Doxazosin—Rigors—Metformin—metabolic syndrome X	0.00138	0.0376	CcSEcCtD
Doxazosin—Ear pain—Metformin—metabolic syndrome X	0.000956	0.0261	CcSEcCtD
Doxazosin—Migraine—Metformin—metabolic syndrome X	0.000803	0.022	CcSEcCtD
Doxazosin—Dehydration—Metformin—metabolic syndrome X	0.000758	0.0207	CcSEcCtD
Doxazosin—Liver function test abnormal—Metformin—metabolic syndrome X	0.000753	0.0206	CcSEcCtD
Doxazosin—Cramp muscle—Metformin—metabolic syndrome X	0.000734	0.0201	CcSEcCtD
Doxazosin—Abdominal distension—Metformin—metabolic syndrome X	0.000709	0.0194	CcSEcCtD
Doxazosin—Angina pectoris—Metformin—metabolic syndrome X	0.000686	0.0188	CcSEcCtD
Doxazosin—Sweating increased—Metformin—metabolic syndrome X	0.000686	0.0188	CcSEcCtD
Doxazosin—Abdominal discomfort—Metformin—metabolic syndrome X	0.000676	0.0185	CcSEcCtD
Doxazosin—Neutropenia—Metformin—metabolic syndrome X	0.000659	0.018	CcSEcCtD
Doxazosin—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000655	0.0179	CcSEcCtD
Doxazosin—Drowsiness—Metformin—metabolic syndrome X	0.000628	0.0172	CcSEcCtD
Doxazosin—Bradycardia—Metformin—metabolic syndrome X	0.000574	0.0157	CcSEcCtD
Doxazosin—Rhinitis—Metformin—metabolic syndrome X	0.000565	0.0155	CcSEcCtD
Doxazosin—Hepatitis—Metformin—metabolic syndrome X	0.000564	0.0154	CcSEcCtD
Doxazosin—Hypoaesthesia—Metformin—metabolic syndrome X	0.000561	0.0154	CcSEcCtD
Doxazosin—Eye disorder—Metformin—metabolic syndrome X	0.000527	0.0144	CcSEcCtD
Doxazosin—Flushing—Metformin—metabolic syndrome X	0.000523	0.0143	CcSEcCtD
Doxazosin—Chills—Metformin—metabolic syndrome X	0.000506	0.0138	CcSEcCtD
Doxazosin—Malnutrition—Metformin—metabolic syndrome X	0.000491	0.0134	CcSEcCtD
Doxazosin—Flatulence—Metformin—metabolic syndrome X	0.000484	0.0132	CcSEcCtD
Doxazosin—Dysgeusia—Metformin—metabolic syndrome X	0.000481	0.0132	CcSEcCtD
Doxazosin—Muscle spasms—Metformin—metabolic syndrome X	0.000472	0.0129	CcSEcCtD
Doxazosin—Vision blurred—Metformin—metabolic syndrome X	0.000463	0.0127	CcSEcCtD
Doxazosin—Tremor—Metformin—metabolic syndrome X	0.00046	0.0126	CcSEcCtD
Doxazosin—Ill-defined disorder—Metformin—metabolic syndrome X	0.000456	0.0125	CcSEcCtD
Doxazosin—Malaise—Metformin—metabolic syndrome X	0.000443	0.0121	CcSEcCtD
Doxazosin—Syncope—Metformin—metabolic syndrome X	0.00044	0.012	CcSEcCtD
Doxazosin—Palpitations—Metformin—metabolic syndrome X	0.000434	0.0119	CcSEcCtD
Doxazosin—Loss of consciousness—Metformin—metabolic syndrome X	0.000432	0.0118	CcSEcCtD
Doxazosin—Hypertension—Metformin—metabolic syndrome X	0.000424	0.0116	CcSEcCtD
Doxazosin—Chest pain—Metformin—metabolic syndrome X	0.000418	0.0114	CcSEcCtD
Doxazosin—Myalgia—Metformin—metabolic syndrome X	0.000418	0.0114	CcSEcCtD
Doxazosin—Discomfort—Metformin—metabolic syndrome X	0.000413	0.0113	CcSEcCtD
Doxazosin—Oedema—Metformin—metabolic syndrome X	0.000401	0.011	CcSEcCtD
Doxazosin—Infection—Metformin—metabolic syndrome X	0.000398	0.0109	CcSEcCtD
Doxazosin—Shock—Metformin—metabolic syndrome X	0.000394	0.0108	CcSEcCtD
Doxazosin—Thrombocytopenia—Metformin—metabolic syndrome X	0.000392	0.0107	CcSEcCtD
Doxazosin—Skin disorder—Metformin—metabolic syndrome X	0.000389	0.0106	CcSEcCtD
Doxazosin—Hyperhidrosis—Metformin—metabolic syndrome X	0.000387	0.0106	CcSEcCtD
Doxazosin—Anorexia—Metformin—metabolic syndrome X	0.000382	0.0104	CcSEcCtD
Doxazosin—Hypotension—Metformin—metabolic syndrome X	0.000374	0.0102	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000365	0.00999	CcSEcCtD
Doxazosin—Paraesthesia—Metformin—metabolic syndrome X	0.00036	0.00984	CcSEcCtD
Doxazosin—Dyspnoea—Metformin—metabolic syndrome X	0.000357	0.00977	CcSEcCtD
Doxazosin—Somnolence—Metformin—metabolic syndrome X	0.000356	0.00974	CcSEcCtD
Doxazosin—Dyspepsia—Metformin—metabolic syndrome X	0.000353	0.00965	CcSEcCtD
Doxazosin—Decreased appetite—Metformin—metabolic syndrome X	0.000348	0.00953	CcSEcCtD
Doxazosin—Fatigue—Metformin—metabolic syndrome X	0.000345	0.00945	CcSEcCtD
Doxazosin—Constipation—Metformin—metabolic syndrome X	0.000343	0.00937	CcSEcCtD
Doxazosin—Feeling abnormal—Metformin—metabolic syndrome X	0.00033	0.00903	CcSEcCtD
Doxazosin—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000328	0.00896	CcSEcCtD
Doxazosin—Urticaria—Metformin—metabolic syndrome X	0.000318	0.00871	CcSEcCtD
Doxazosin—Abdominal pain—Metformin—metabolic syndrome X	0.000317	0.00867	CcSEcCtD
Doxazosin—Asthenia—Metformin—metabolic syndrome X	0.000288	0.00786	CcSEcCtD
Doxazosin—Pruritus—Metformin—metabolic syndrome X	0.000284	0.00776	CcSEcCtD
Doxazosin—Diarrhoea—Metformin—metabolic syndrome X	0.000274	0.0075	CcSEcCtD
Doxazosin—Dizziness—Metformin—metabolic syndrome X	0.000265	0.00725	CcSEcCtD
Doxazosin—Vomiting—Metformin—metabolic syndrome X	0.000255	0.00697	CcSEcCtD
Doxazosin—Rash—Metformin—metabolic syndrome X	0.000253	0.00691	CcSEcCtD
Doxazosin—Dermatitis—Metformin—metabolic syndrome X	0.000252	0.0069	CcSEcCtD
Doxazosin—Headache—Metformin—metabolic syndrome X	0.000251	0.00687	CcSEcCtD
Doxazosin—Nausea—Metformin—metabolic syndrome X	0.000238	0.00651	CcSEcCtD
Doxazosin—ADRA2A—Signaling Pathways—RBP4—metabolic syndrome X	1.12e-05	0.000474	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—G6PD—metabolic syndrome X	1.11e-05	0.000472	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—SCARB1—metabolic syndrome X	1.1e-05	0.000467	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	1.1e-05	0.000466	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—G6PD—metabolic syndrome X	1.09e-05	0.000461	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—HDAC3—metabolic syndrome X	1.09e-05	0.000461	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HTR2C—metabolic syndrome X	1.08e-05	0.000459	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—SREBF1—metabolic syndrome X	1.07e-05	0.000453	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—AGT—metabolic syndrome X	1.07e-05	0.000452	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APOC3—metabolic syndrome X	1.06e-05	0.000452	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GCKR—metabolic syndrome X	1.06e-05	0.000451	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—LPA—metabolic syndrome X	1.06e-05	0.000451	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—HDAC3—metabolic syndrome X	1.06e-05	0.00045	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—CCL2—metabolic syndrome X	1.06e-05	0.000449	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CCL5—metabolic syndrome X	1.05e-05	0.000446	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CYBA—metabolic syndrome X	1.05e-05	0.000445	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	1.05e-05	0.000445	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	1.05e-05	0.000445	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—AGT—metabolic syndrome X	1.04e-05	0.000443	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—HMGCR—metabolic syndrome X	1.04e-05	0.000441	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GOT2—metabolic syndrome X	1.04e-05	0.000441	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GCKR—metabolic syndrome X	1.04e-05	0.00044	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—LPA—metabolic syndrome X	1.04e-05	0.00044	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PLA2G6—metabolic syndrome X	1.03e-05	0.000436	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—GHRL—metabolic syndrome X	1.03e-05	0.000435	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—G6PD—metabolic syndrome X	1.02e-05	0.000435	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	1.02e-05	0.000433	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOA5—metabolic syndrome X	1.02e-05	0.000432	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	1e-05	0.000426	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	1e-05	0.000426	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—HDAC3—metabolic syndrome X	9.99e-06	0.000424	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOA5—metabolic syndrome X	9.93e-06	0.000422	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOC3—metabolic syndrome X	9.89e-06	0.00042	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	9.88e-06	0.00042	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—LPA—metabolic syndrome X	9.76e-06	0.000415	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GCKR—metabolic syndrome X	9.76e-06	0.000415	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CNR1—metabolic syndrome X	9.71e-06	0.000412	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—AGT—metabolic syndrome X	9.68e-06	0.000411	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	9.68e-06	0.000411	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HTR2C—metabolic syndrome X	9.61e-06	0.000408	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	9.57e-06	0.000407	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IGF2—metabolic syndrome X	9.56e-06	0.000406	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	9.47e-06	0.000402	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—AGT—metabolic syndrome X	9.46e-06	0.000402	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—TRIB3—metabolic syndrome X	9.46e-06	0.000402	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	9.45e-06	0.000401	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOA5—metabolic syndrome X	9.36e-06	0.000397	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CYBA—metabolic syndrome X	9.3e-06	0.000395	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—APOB—metabolic syndrome X	9.28e-06	0.000394	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ABCA1—metabolic syndrome X	9.25e-06	0.000393	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—SLC2A4—metabolic syndrome X	9.25e-06	0.000393	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—TRIB3—metabolic syndrome X	9.23e-06	0.000392	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—GHRL—metabolic syndrome X	9.11e-06	0.000387	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCL5—metabolic syndrome X	9.07e-06	0.000385	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PLA2G4A—metabolic syndrome X	9.03e-06	0.000384	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GGT1—metabolic syndrome X	8.96e-06	0.000381	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GOT1—metabolic syndrome X	8.96e-06	0.000381	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HTR2C—metabolic syndrome X	8.92e-06	0.000379	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	8.88e-06	0.000377	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—LPL—metabolic syndrome X	8.86e-06	0.000376	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—AGT—metabolic syndrome X	8.79e-06	0.000373	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CCL2—metabolic syndrome X	8.77e-06	0.000373	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	8.7e-06	0.000369	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CYBA—metabolic syndrome X	8.64e-06	0.000367	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CNR1—metabolic syndrome X	8.62e-06	0.000366	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—NAMPT—metabolic syndrome X	8.48e-06	0.00036	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—GHRL—metabolic syndrome X	8.46e-06	0.000359	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	8.43e-06	0.000358	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—LIPC—metabolic syndrome X	8.43e-06	0.000358	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GCK—metabolic syndrome X	8.43e-06	0.000358	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOC3—metabolic syndrome X	8.38e-06	0.000356	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NAMPT—metabolic syndrome X	8.28e-06	0.000352	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—LIPC—metabolic syndrome X	8.23e-06	0.000349	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GCK—metabolic syndrome X	8.23e-06	0.000349	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOC3—metabolic syndrome X	8.18e-06	0.000347	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CETP—metabolic syndrome X	8.13e-06	0.000345	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CNR1—metabolic syndrome X	8.01e-06	0.00034	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CETP—metabolic syndrome X	7.94e-06	0.000337	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IGF2—metabolic syndrome X	7.94e-06	0.000337	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	7.8e-06	0.000331	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	7.79e-06	0.000331	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CCL2—metabolic syndrome X	7.79e-06	0.000331	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—SCARB1—metabolic syndrome X	7.79e-06	0.000331	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GCK—metabolic syndrome X	7.75e-06	0.000329	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—LIPC—metabolic syndrome X	7.75e-06	0.000329	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOC3—metabolic syndrome X	7.71e-06	0.000327	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APOB—metabolic syndrome X	7.71e-06	0.000327	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—APOB—metabolic syndrome X	7.6e-06	0.000323	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—SCARB1—metabolic syndrome X	7.6e-06	0.000323	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	7.58e-06	0.000322	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AGT—metabolic syndrome X	7.58e-06	0.000322	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—SREBF1—metabolic syndrome X	7.56e-06	0.000321	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCL5—metabolic syndrome X	7.52e-06	0.00032	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PLA2G4A—metabolic syndrome X	7.5e-06	0.000318	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CETP—metabolic syndrome X	7.48e-06	0.000318	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TGFB1—metabolic syndrome X	7.44e-06	0.000316	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—LEP—metabolic syndrome X	7.43e-06	0.000316	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—APOE—metabolic syndrome X	7.43e-06	0.000316	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PLA2G4A—metabolic syndrome X	7.4e-06	0.000314	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—SREBF1—metabolic syndrome X	7.38e-06	0.000313	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—LPL—metabolic syndrome X	7.36e-06	0.000312	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—HMGCR—metabolic syndrome X	7.36e-06	0.000312	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GOT2—metabolic syndrome X	7.36e-06	0.000312	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—APOA1—metabolic syndrome X	7.34e-06	0.000312	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—LPL—metabolic syndrome X	7.26e-06	0.000308	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CCL2—metabolic syndrome X	7.24e-06	0.000308	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—HMGCR—metabolic syndrome X	7.18e-06	0.000305	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GOT2—metabolic syndrome X	7.18e-06	0.000305	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	7.16e-06	0.000304	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IGF2—metabolic syndrome X	7.05e-06	0.000299	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	7.04e-06	0.000299	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	6.95e-06	0.000295	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CD36—metabolic syndrome X	6.9e-06	0.000293	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APOB—metabolic syndrome X	6.84e-06	0.000291	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GOT2—metabolic syndrome X	6.77e-06	0.000287	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	6.77e-06	0.000287	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCL5—metabolic syndrome X	6.68e-06	0.000284	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	6.66e-06	0.000283	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	6.63e-06	0.000282	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IRS1—metabolic syndrome X	6.63e-06	0.000281	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ABCA1—metabolic syndrome X	6.56e-06	0.000278	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—SLC2A4—metabolic syndrome X	6.56e-06	0.000278	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IGF2—metabolic syndrome X	6.55e-06	0.000278	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—LPL—metabolic syndrome X	6.53e-06	0.000278	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PPARA—metabolic syndrome X	6.41e-06	0.000272	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ABCA1—metabolic syndrome X	6.4e-06	0.000272	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	6.4e-06	0.000272	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOB—metabolic syndrome X	6.36e-06	0.00027	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GGT1—metabolic syndrome X	6.35e-06	0.00027	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GOT1—metabolic syndrome X	6.35e-06	0.00027	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—INS—metabolic syndrome X	6.35e-06	0.00027	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AGT—metabolic syndrome X	6.29e-06	0.000267	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCL2—metabolic syndrome X	6.25e-06	0.000265	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—AGT—metabolic syndrome X	6.21e-06	0.000264	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCL5—metabolic syndrome X	6.21e-06	0.000264	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GGT1—metabolic syndrome X	6.2e-06	0.000263	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GOT1—metabolic syndrome X	6.2e-06	0.000263	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	6.19e-06	0.000263	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—LEP—metabolic syndrome X	6.17e-06	0.000262	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APOE—metabolic syndrome X	6.17e-06	0.000262	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IGF1—metabolic syndrome X	6.14e-06	0.000261	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APOA1—metabolic syndrome X	6.1e-06	0.000259	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—APOE—metabolic syndrome X	6.09e-06	0.000258	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—LPL—metabolic syndrome X	6.07e-06	0.000258	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	6.03e-06	0.000256	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	6.03e-06	0.000256	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—APOA1—metabolic syndrome X	6.02e-06	0.000256	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GOT1—metabolic syndrome X	5.84e-06	0.000248	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GGT1—metabolic syndrome X	5.84e-06	0.000248	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SERPINE1—metabolic syndrome X	5.83e-06	0.000248	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AGT—metabolic syndrome X	5.59e-06	0.000237	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NOS3—metabolic syndrome X	5.57e-06	0.000236	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IRS1—metabolic syndrome X	5.5e-06	0.000234	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	5.48e-06	0.000233	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	5.48e-06	0.000233	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	5.41e-06	0.00023	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOB—metabolic syndrome X	5.39e-06	0.000229	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PPARG—metabolic syndrome X	5.3e-06	0.000225	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—INS—metabolic syndrome X	5.27e-06	0.000224	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOB—metabolic syndrome X	5.26e-06	0.000223	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	5.24e-06	0.000223	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—INS—metabolic syndrome X	5.2e-06	0.000221	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	5.19e-06	0.000221	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCL2—metabolic syndrome X	5.18e-06	0.00022	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	5.17e-06	0.00022	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—LPL—metabolic syndrome X	5.14e-06	0.000218	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	5.12e-06	0.000217	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IGF1—metabolic syndrome X	5.1e-06	0.000216	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	5.09e-06	0.000216	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	5.09e-06	0.000216	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	5.03e-06	0.000214	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—LPL—metabolic syndrome X	5.02e-06	0.000213	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOB—metabolic syndrome X	4.96e-06	0.00021	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CD36—metabolic syndrome X	4.89e-06	0.000208	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	4.89e-06	0.000208	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SERPINE1—metabolic syndrome X	4.84e-06	0.000206	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	4.82e-06	0.000205	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CD36—metabolic syndrome X	4.77e-06	0.000203	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—AKT1—metabolic syndrome X	4.77e-06	0.000203	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ALB—metabolic syndrome X	4.77e-06	0.000202	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—LPL—metabolic syndrome X	4.73e-06	0.000201	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL6—metabolic syndrome X	4.7e-06	0.000199	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	4.68e-06	0.000199	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	4.62e-06	0.000196	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	4.6e-06	0.000196	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—NOS3—metabolic syndrome X	4.56e-06	0.000194	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARA—metabolic syndrome X	4.54e-06	0.000193	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	4.54e-06	0.000193	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	4.53e-06	0.000192	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CD36—metabolic syndrome X	4.5e-06	0.000191	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARA—metabolic syndrome X	4.44e-06	0.000188	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AGT—metabolic syndrome X	4.4e-06	0.000187	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	4.35e-06	0.000185	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—AKT1—metabolic syndrome X	4.33e-06	0.000184	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOE—metabolic syndrome X	4.31e-06	0.000183	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	4.3e-06	0.000183	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AGT—metabolic syndrome X	4.3e-06	0.000182	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	4.28e-06	0.000182	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOA1—metabolic syndrome X	4.26e-06	0.000181	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOE—metabolic syndrome X	4.21e-06	0.000179	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	4.21e-06	0.000179	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARA—metabolic syndrome X	4.18e-06	0.000178	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	4.17e-06	0.000177	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOA1—metabolic syndrome X	4.16e-06	0.000177	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	4.1e-06	0.000174	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AGT—metabolic syndrome X	4.05e-06	0.000172	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	3.99e-06	0.00017	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOE—metabolic syndrome X	3.97e-06	0.000168	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	3.96e-06	0.000168	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOA1—metabolic syndrome X	3.92e-06	0.000167	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	3.9e-06	0.000165	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	3.81e-06	0.000162	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARG—metabolic syndrome X	3.76e-06	0.00016	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—INS—metabolic syndrome X	3.68e-06	0.000156	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TGFB1—metabolic syndrome X	3.68e-06	0.000156	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARG—metabolic syndrome X	3.67e-06	0.000156	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—INS—metabolic syndrome X	3.6e-06	0.000153	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	3.6e-06	0.000153	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	3.52e-06	0.000149	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	3.46e-06	0.000147	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARG—metabolic syndrome X	3.45e-06	0.000147	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—INS—metabolic syndrome X	3.39e-06	0.000144	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ALB—metabolic syndrome X	3.38e-06	0.000143	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ALB—metabolic syndrome X	3.3e-06	0.00014	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	3.27e-06	0.000139	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—NOS3—metabolic syndrome X	3.23e-06	0.000137	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	3.22e-06	0.000137	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	3.19e-06	0.000136	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NOS3—metabolic syndrome X	3.15e-06	0.000134	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ALB—metabolic syndrome X	3.11e-06	0.000132	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	3.05e-06	0.00013	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NOS3—metabolic syndrome X	2.97e-06	0.000126	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	2.97e-06	0.000126	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	2.95e-06	0.000125	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTGS2—metabolic syndrome X	2.88e-06	0.000122	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL6—metabolic syndrome X	2.77e-06	0.000118	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	2.72e-06	0.000115	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	2.71e-06	0.000115	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AKT1—metabolic syndrome X	2.56e-06	0.000109	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	2.52e-06	0.000107	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	2.3e-06	9.78e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	2.12e-06	9.02e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—AKT1—metabolic syndrome X	2.1e-06	8.9e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	2.04e-06	8.68e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	1.9e-06	8.07e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	1.89e-06	8.01e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	1.75e-06	7.44e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AKT1—metabolic syndrome X	1.49e-06	6.31e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AKT1—metabolic syndrome X	1.45e-06	6.16e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AKT1—metabolic syndrome X	1.37e-06	5.8e-05	CbGpPWpGaD
